424 related articles for article (PubMed ID: 27340145)
21. Mortality, Morbidity, and Costs After Implementation of a Vasopressin Guideline in Medical Intensive Care Patients With Septic Shock: An Interrupted Time Series Analysis.
Bauer SR; Sacha GL; Reddy AJ
Ann Pharmacother; 2020 Apr; 54(4):314-321. PubMed ID: 31679395
[No Abstract] [Full Text] [Related]
22. Narrative Review of Controversies Involving Vasopressin Use in Septic Shock and Practical Considerations.
Der-Nigoghossian C; Hammond DA; Ammar MA
Ann Pharmacother; 2020 Jul; 54(7):706-714. PubMed ID: 31958982
[No Abstract] [Full Text] [Related]
23. Concomitant vasopressin and hydrocortisone therapy on short-term hemodynamic effects and vasopressor requirements in refractory septic shock.
Buckley MS; MacLaren R
J Crit Care; 2017 Dec; 42():6-11. PubMed ID: 28647651
[TBL] [Abstract][Full Text] [Related]
24. Vasopressin or norepinephrine in early hyperdynamic septic shock: a randomized clinical trial.
Lauzier F; Lévy B; Lamarre P; Lesur O
Intensive Care Med; 2006 Nov; 32(11):1782-9. PubMed ID: 17019548
[TBL] [Abstract][Full Text] [Related]
25. Beneficial effects of short-term vasopressin infusion during severe septic shock.
Patel BM; Chittock DR; Russell JA; Walley KR
Anesthesiology; 2002 Mar; 96(3):576-82. PubMed ID: 11873030
[TBL] [Abstract][Full Text] [Related]
26. Radial to femoral arterial blood pressure differences in septic shock patients receiving high-dose norepinephrine therapy.
Kim WY; Jun JH; Huh JW; Hong SB; Lim CM; Koh Y
Shock; 2013 Dec; 40(6):527-31. PubMed ID: 24089010
[TBL] [Abstract][Full Text] [Related]
27. The Therapeutic Role of Vasopressin on Improving Lactate Clearance During and After Vasogenic Shock: Microcirculation, Is It The Black Box?
Barzegar E; Ahmadi A; Mousavi S; Nouri M; Mojtahedzadeh M
Acta Med Iran; 2016 Jan; 54(1):15-23. PubMed ID: 26853286
[TBL] [Abstract][Full Text] [Related]
28. Low-dose vasopressin in the treatment of vasodilatory septic shock.
Malay MB; Ashton RC; Landry DW; Townsend RN
J Trauma; 1999 Oct; 47(4):699-703; discussion 703-5. PubMed ID: 10528604
[TBL] [Abstract][Full Text] [Related]
29. Evaluating Vasopressor Discontinuation Strategies in Patients With Septic Shock on Concomitant Norepinephrine and Vasopressin Infusions.
Musallam N; Altshuler D; Merchan C; Zakhary B; Aberle C; Papadopoulos J
Ann Pharmacother; 2018 Aug; 52(8):733-739. PubMed ID: 29560736
[TBL] [Abstract][Full Text] [Related]
30. Disparities in hemodynamic resuscitation of the obese critically ill septic shock patient.
Adams C; Tucker C; Allen B; McRae A; Balazh J; Horst S; Johnson D; Ferreira J
J Crit Care; 2017 Feb; 37():219-223. PubMed ID: 27969574
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and Safety of Vasopressin as First-Line Treatment of Distributive and Hemorrhagic Shock States.
Haan BJ; Cadiz ML; Natavio AM
Ann Pharmacother; 2020 Mar; 54(3):213-218. PubMed ID: 31625395
[No Abstract] [Full Text] [Related]
32. Optimal norepinephrine-equivalent dose to initiate epinephrine in patients with septic shock.
Ammar MA; Limberg EC; Lam SW; Ammar AA; Sacha GL; Reddy AJ; Bauer SR
J Crit Care; 2019 Oct; 53():69-74. PubMed ID: 31202160
[TBL] [Abstract][Full Text] [Related]
33. The long-term survival rate of catecholamine-resistant septic shock in Japanese patients who received vasopressin therapy.
Sawa N; Ubara Y; Katori H; Hoshino J; Suwabe T; Takemoto F; Uchida N; Masuoka K; Wake A; Taniguchi S; Takaichi K
Clin Nephrol; 2009 Aug; 72(2):129-36. PubMed ID: 19640370
[TBL] [Abstract][Full Text] [Related]
34. Impact of Norepinephrine Weight-Based Dosing Compared With Non-Weight-Based Dosing in Achieving Time to Goal Mean Arterial Pressure in Obese Patients With Septic Shock.
Droege CA; Ernst NE
Ann Pharmacother; 2017 Jul; 51(7):614-616. PubMed ID: 28205455
[TBL] [Abstract][Full Text] [Related]
35. High-dose vasopressin is not superior to norepinephrine in septic shock.
Klinzing S; Simon M; Reinhart K; Bredle DL; Meier-Hellmann A
Crit Care Med; 2003 Nov; 31(11):2646-50. PubMed ID: 14605537
[TBL] [Abstract][Full Text] [Related]
36. Norepinephrine and Vasopressin Compared With Norepinephrine and Epinephrine in Adults With Septic Shock.
Menich BE; Miano TA; Patel GP; Hammond DA
Ann Pharmacother; 2019 Sep; 53(9):877-885. PubMed ID: 30957512
[No Abstract] [Full Text] [Related]
37. Hemodynamic Response to Vasopressin Dosage of 0.03 Units/Min vs. 0.04 Units/Min in Patients With Septic Shock.
Bauer SR; Sacha GL; Lam SW; Wang L; Reddy AJ; Duggal A; Vachharajani V
J Intensive Care Med; 2022 Jan; 37(1):92-99. PubMed ID: 33251906
[TBL] [Abstract][Full Text] [Related]
38. The effects of vasopressin on systemic hemodynamics in catecholamine-resistant septic and postcardiotomy shock: a retrospective analysis.
Dünser MW; Mayr AJ; Ulmer H; Ritsch N; Knotzer H; Pajk W; Luckner G; Mutz NJ; Hasibeder WR
Anesth Analg; 2001 Jul; 93(1):7-13. PubMed ID: 11429329
[TBL] [Abstract][Full Text] [Related]
39. Dynamic arterial elastance predicts mean arterial pressure decrease associated with decreasing norepinephrine dosage in septic shock.
Guinot PG; Bernard E; Levrard M; Dupont H; Lorne E
Crit Care; 2015 Jan; 19(1):14. PubMed ID: 25598221
[TBL] [Abstract][Full Text] [Related]
40. Hemodynamic and metabolic effects of low-dose vasopressin infusions in vasodilatory septic shock.
Tsuneyoshi I; Yamada H; Kakihana Y; Nakamura M; Nakano Y; Boyle WA
Crit Care Med; 2001 Mar; 29(3):487-93. PubMed ID: 11373409
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
